{"nct_id":"NCT04502888","title":"Ph1 Study of SL-172154 Administered Intratumorally in Subjects With Squamous Cell Carcinoma of the Head and Neck or Skin","status":"TERMINATED","status_verified_date":"2025-01","start_date":"2020-09-17","start_date_type":"ACTUAL","primary_completion_date":"2022-04-08","primary_completion_date_type":"ACTUAL","completion_date":"2022-04-08","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["STTK"]}